ReproCELLorp (TSE:4978) Accounts Payable & Accrued Expense : 円1,840 Mil (As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is ReproCELLorp Accounts Payable & Accrued Expense?

ReproCELLorp's quarterly accounts payable & accrued expense increased from Jun. 2024 (円0 Mil) to Sep. 2024 (円194 Mil) and increased from Sep. 2024 (円194 Mil) to Dec. 2024 (円1,840 Mil).

ReproCELLorp's annual accounts payable & accrued expense declined from Mar. 2023 (円373 Mil) to Mar. 2024 (円255 Mil) but then increased from Mar. 2024 (円255 Mil) to Mar. 2025 (円257 Mil).

ReproCELLorp Accounts Payable & Accrued Expense Historical Data

The historical data trend for ReproCELLorp's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ReproCELLorp Accounts Payable & Accrued Expense Chart

ReproCELLorp Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

272.92

361.34

372.84

255.46

257.06

ReproCELLorp Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															255.46	-	193.97	1,840.25	257.06

ReproCELLorp Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

ReproCELLorp Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReproCELL Incorp (TSE:4978) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

6RC:Germany

Address

KDX Shin-Yokohama 381 Bldg. 9F, 3-8-11, Shin-Yokohama, Kohoku-ku, Kanagawa, Yokohama, JPN, 222-0033

Website

https://www.reprocell.com

ReproCELL Incorp is one of the leading stem cell research company in Japan. The company provides stem cell services, predictive drug discovery services, tissue services, and molecular services.

ReproCELLorp Headlines

No Headlines